Can People with High Cholesterol Take Omega-3?

High cholesterol is a common cardiovascular risk factor, and many people wonder whether omega-3 fatty acids are a safe or effective addition to their lipid management plan. Evidence shows that omega-3s—particularly the marine-derived eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)—have reproducible effects on triglycerides and broader cardiovascular biology, but their relationship with LDL cholesterol is more nuanced.

How omega-3s affect lipid profiles

Omega-3s typically lower triglyceride levels substantially, with typical therapeutic reductions ranging from 20–50% depending on dose and baseline values. EPA and DHA influence hepatic lipid metabolism, reducing very-low-density lipoprotein (VLDL) production and promoting triglyceride clearance. By contrast, their effect on low-density lipoprotein (LDL) is variable: some mixed EPA/DHA formulations can cause small increases in LDL in certain individuals, whereas EPA-only preparations tend to be neutral with respect to LDL.

Cardiovascular and inflammatory benefits

Beyond lipid changes, omega-3s have anti-inflammatory and endothelial effects that support cardiovascular health. They alter eicosanoid production, reduce pro-inflammatory cytokines, and can improve vascular function and plaque stability. Large clinical trials using high-purity EPA have demonstrated reductions in major cardiovascular events in high-risk populations, most of whom were also receiving standard LDL-lowering therapies.

Safety and practical considerations

Omega-3 supplements are generally well tolerated. Common minor adverse effects include gastrointestinal discomfort or a fishy aftertaste. At higher doses (>3 g/day), the risk of bleeding can increase, especially for people taking anticoagulant or antiplatelet medications, so such regimens should be supervised by a clinician. Purity is also important—pharmaceutical-grade or third-party–tested supplements reduce exposure to contaminants like mercury or PCBs.

How to incorporate omega-3s into a cholesterol plan

For people with elevated triglycerides or mixed dyslipidemia, adding a therapeutic dose of EPA+DHA (often 2–4 g/day) can be effective for triglyceride control when combined with diet, exercise, and prescribed lipid-lowering medications. However, omega-3s should not replace statins, ezetimibe, or PCSK9 inhibitors when LDL lowering is the primary goal. Coordination with a healthcare provider ensures appropriate dosing and monitoring of lipid panels.

Resources and further reading

For an evidence-focused overview of omega-3s and high cholesterol, see this detailed discussion: omega-3 supplements and high cholesterol. To read about signs of low omega-3 status, consult this guide on omega-3 deficiency symptoms. If you are following a ketogenic diet and are interested in compatible nutraceuticals, review a curated list of keto-friendly supplements to support fat burn and an accompanying summary on Telegraph.

Plant-based ALA sources (flaxseed, chia, walnuts) contribute to overall intake but convert inefficiently to EPA/DHA; algae-based DHA supplements are an alternative for those avoiding fish. When considering any supplement, choose formulations with clear purity testing and discuss potential interactions with your clinician.